ISDA

Deposition Date 2015-10-21

Release Date 2015-12-02

Last Version Date 2024-03-06

Entry Detail

PDB ID:

5EDR

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

EGFR kinase (T790M/L858R) with inhibitor compound 27: ~{N}-(1~{H}-indazol-3-yl)-7,7-dimethyl-2-(2-methylpyrazol-3-yl)-5~{H}-furo[3,4-d]pyrimidin-4-amine

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.60 Å

R-Value Free:

0.21

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

I 2 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Epidermal growth factor receptor
Gene (Uniprot):EGFR
Mutations:T790M, L858R, E865A, E866A, K867A
Chain IDs:A
Chain Length:331
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00533 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

5N4

Primary Citation

4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase.

Hanan, E.J, Baumgardner, M, Bryan, M.C, Chen, Y, Eigenbrot, C, Fan, P, Gu, X.H, La, H, Malek, S, Purkey, H.E, Schaefer, G, Schmidt, S, Sideris, S, Yen, I, Yu, C, Heffron, T.P.Show

Bioorg.Med.Chem.Lett. 26 534 539 (2016)

PMID: 26639762 DOI: 10.1016/j.bmcl.2015.11.078

Abstact

The treatment of epidermal growth factor receptor (EGFR)-driven non-small cell lung cancers with the T790M resistance mutation remains a significant unmet medical need. We report the identification of 4-aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of EGFR, with excellent activity against the T790M resistance double mutants and initial single activating mutants. Using an optimization strategy focused on structure-based design and improving PK properties through metabolite identification, we obtained advanced leads with high oral exposure.

Legend

Protein

Chemical

Disease

Primary Citation of related structures